Intraoperative placing of drains decreases the incidence of lymphocele and deep vein thrombosis after renal transplantation

BJU International

Volumn 101, Issue 11, 2008, Pages 1415-1419

  Derweesh, Ithaar H ^a,b   Ismail, Hazem R ^a   Goldfarb, David A ^a   Araki, Motoo ^a   Zhou, Lingmei ^a   Modlin, Charles ^a   Krishnamurthi, Venkatesh ^a   Flechner, Stuart M ^a   Novick, Andrew C ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Calcineurin inhibitor; Deep vein thrombosis; Drain; Kidney transplantation; Lymphocele; Sirolimus

Indexed keywords

BASILIXIMAB; CALCINEURIN INHIBITOR; CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; DEEP VEIN THROMBOSIS; DRAIN; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INTRAOPERATIVE PERIOD; KIDNEY TRANSPLANTATION; LOADING DRUG DOSE; LYMPHOCELE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECIPIENT; RISK FACTOR; WOUND COMPLICATION;

ADOLESCENT; ADULT; AGED; DRAINAGE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTRAOPERATIVE CARE; KIDNEY TRANSPLANTATION; LYMPHOCELE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 43049093056     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.07427.x     Document Type: Article

References (26)

1. Hariharan S, Johnson CP, Bresnahan BA et al. Improved graft survival after renal transplantation in the United States, 1988-96. N Engl J Med 2000 342 : 605 12
2. Langer RM, Kahan BD. Incidence, therapy, and consequences of lymphocele after sirolimus-cyclosporine-prednisone immunosuppression in renal transplant recipients. Transplantation 2002 74 : 804 8
3. Flechner SM, Zhou L, Derweesh I et al. The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients. Transplantation 2003 76 : 1729 34
4. Knight RJ, Villa M, Laskey R et al. Risk factors for impaired wound healing in sirolimus-treated renal transplant recipients. Clin Transplant 2007 21 : 460 5
5. Zanker B, Schneeberger H, Rothenpieler U et al. Mycophenolate mofetil-based, cyclosporine-free induction and maintenance immunosuppression: first-3-months analysis of efficacy and safety in two cohorts of renal allograft recipients. Transplantation 1998 66 : 44 9
6. Mehrabi A, Fonouni H, Wente M et al. Wound complications following kidney and liver transplantation. Clin Transplant 2006 20 (Suppl. 17 97 110
7. Valente JF, Hricik D, Weigel K et al. Comparison of sirolimus vs. mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation. Am J Transplant 2003 3 : 1128 34
8. Lo A, Egidi MF, Gaber LW, Gaber AO. Observations on the use of sirolimus and tacrolimus in high-risk renal transplant recipients. Transplant Proc 2003 35 : S105 8
9. Zeeh J, Inglin R, Baumann G et al. Mycophenolate mofetil impairs healing of left-sided colon anastomoses. Transplantation 2001 71 : 1429 35
10. Sehgal SN. Rapamune (RAPA, rapamycin, sirolimus). mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression. Clin Biochem 1998 31 : 335 40
11. Sehgal SN. Sirolimus: its discovery, biological properties, and mechanism of action. Transplant Proc 2003 35 (3 Suppl. 7S 14S
12. Gregory CR, Huang X, Pratt RE et al. Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement. Transplantation 1995 59 : 655 61
13. Humar A, Ramcharan T, Denny R et al. Are wound complications after a kidney transplant more common with modern immunosuppression? Transplantation 2001 72 : 1920 3
14. Pollak R, Veremis SA, Maddux MS, Mozes MF. The natural history of and therapy for perirenal fluid collections following renal transplantation. J Urol 1988 140 : 716 20
15. Silver TM, Campbell D, Wicks JD et al. Peritransplant fluid collections. Ultrasound evaluation and clinical significance. Radiology 1981 38 : 145 51
16. Malovrh M, Kandus A, Buturovic-Ponikvar J et al. Frequency and clinical influence of lymphoceles after kidney transplantation. Transplant Proc 1990 22 : 1423 4
17. Kay R, Fuchs E, Barry JM. Management of postoperative pelvic lymphoceles. Urology 1980 15 : 345 7
18. Khauli RB, Stoff JS, Lovewell T et al. Post-transplant lymphoceles: a critical look into the risk factors, pathophysiology and management. J Urol 1993 150 : 22 6
19. Amante AJ, Kahan BD. Technical complications of renal transplantation. Surg Clin North Am 1994 74 : 1117 31
20. Lundin C, Bersztel A, Wahlberg J, Wadstrom J. Low molecular weight heparin prophylaxis increases the incidence of lymphocele after kidney transplantation. Ups J Med Sci 2002 107 : 9 15
21. Chin A, Ragavendra N, Hilborne L, Gritsch HA. Fibrin sealant sclerotherapy for treatment of lymphoceles following renal transplantation. J Urol 2003 170 : 380 3
22. Chandrasekaran D, Meyyappan RM, Rajaraman T. Instillation of povidone iodine to treat and prevent lymphocele after renal transplantation. BJU Int 2003 91 : 296
23. Gill IS, Hodge EE, Munch LC et al. Transperitoneal marsupialization of lymphoceles: a comparison of laparoscopic and open techniques. J Urol 1995 153 : 706 11
24. Oyen O, Siwach V, Line PD et al. Improvement of post-transplant lymphocele treatment in the laparoscopic era. Transpl Int 2002 15 : 406 10
25. Fuller TF, Kang SM, Hirose R, Feng S, Stock PG, Freise CE. Management of lymphoceles after renal transplantation: laparoscopic versus open drainage. J Urol 2003 169 : 2022 5
26. Flechner SM, Goldfarb D, Modlin C et al. Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine. Transplantation 2002 74 : 1070 6